Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
10/2013
10/31/2013WO2013159422A1 Small molecular peptide and use thereof
10/31/2013WO2013114240A3 Method for obtaining glycoprotein composition
10/31/2013US20130289385 Deep brain stimulation of memory circuits in alzheimer's disease
10/31/2013US20130287687 Compounds, compositions, methods of synthesis, and methods of treatment
10/31/2013US20130287686 Fluorinated 2-Amino-4-(Benzylamino)Phenylcarbamate Derivatives
10/31/2013US20130287685 Her2 binding peptides labeled with aluminium-[18] fluoride complexed by nota
10/31/2013US20130287681 Somatostatin receptor-based cancer therapy
10/30/2013EP2657253A2 Anti-CD79b antibodies and immunoconjugates and methods of use
10/30/2013EP2656859A2 Compositions and methods for topical application and transdermal delivery of botulinum toxins
10/30/2013EP2654804A1 Her2 binding peptides labeled with aluminium-[18]fluoride complexed by nota
10/30/2013EP2654803A1 Radiolabled her2 binding peptides
10/30/2013EP2654798A1 Use of aniline i the radiostabilization of oxime ligation
10/30/2013EP2654796A1 Agents for clearing biomolecules from circulation
10/30/2013CN103380118A Tau成像探针 Tau imaging probe
10/30/2013CN103372221A Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
10/30/2013CN103372220A Pharmaceutical microsphere for embolization
10/30/2013CN101557801B Hydrogels containing low molecular weight alginates and biostructures made therefrom
10/30/2013CA2775869A1 Single photon emission computed tomography imaging method
10/29/2013US8568689 uPAR-targeting contrast agents
10/29/2013US8568688 Aerosol for controlling insect pests
10/29/2013CA2592302C Positron emission tomography imaging method
10/24/2013WO2013156225A1 Optimizing ungual treatment by quantitative autoradiography
10/24/2013US20130280168 Flexible and/or Elastic Brachytherapy Seed or Sirand
10/24/2013US20130280164 Polypeptides having affinity for her2
10/24/2013US20130280163 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
10/23/2013EP2653478A1 A novel antigen associated with the neovasculature of tumour metastases
10/23/2013EP2651970A1 Serum amyloid p protein
10/23/2013EP2651457A1 Radioiodinated fatty acids
10/23/2013EP2651453A1 Compounds for diagnosing diseases associated with the expression of muc5ac
10/23/2013EP2651447A1 Entrapment of radionuclides in nanoparticle compositions
10/23/2013CN103370084A Use of aniline in the radiostabilization of oxime ligation
10/23/2013CN103360494A Completely anti-CD20 human monoclonal antibody and application thereof
10/22/2013US8563682 Guanylylcyclase C ligands
10/22/2013US8563600 Diagnostic compounds
10/22/2013US8563012 Compositions and methods for administering compartmentalized frozen particles
10/22/2013US8562952 Methods for manipulating satiety
10/22/2013US8562949 Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents
10/22/2013US8562948 Somatostatin analogs with inhibitory activity to growth hormone release
10/22/2013US8562947 Oxidized avidin with high residency time in the treated tissues
10/22/2013US8562946 Miniaturized 62Zn/62Cu generator for high concentration clinical delivery of 62Cu kit formulation for the facile preparation of radiolabeled Cu-bis(thiosemicarbazone) compounds
10/22/2013US8562945 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
10/22/2013US8562944 PAA nanoparticles for enhancement of tumor imaging
10/22/2013US8562943 Quality control methods for oil-in-water emulsions containing squalene
10/22/2013CA2473526C Polyalkylene polymer compounds and uses thereof
10/17/2013WO2013153197A1 Ultrafine nanoparticles as multimodal contrast agent
10/17/2013US20130273042 Treatment of multiple sclerosis
10/17/2013US20130273039 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
10/17/2013US20130272961 Radioiodinated guanidines
10/17/2013US20130272960 Radioiodinated fatty acids
10/17/2013US20130272959 Agents for clearing biomolecules from circulation
10/17/2013US20130272958 Anti-ceacam6 antibodies and uses thereof
10/17/2013US20130272956 (11beta, 17alpha)-11-(4-(2-11C-ACETYL)PHENYL)-17,23-EPOXY-19,24-DINORCHOLA-4,9,20-TRIEN-3-ONE
10/16/2013EP2650006A1 Analogues of exendin-4 and exendin-3
10/16/2013EP2648767A1 Radiotracer compositions
10/16/2013EP2648766A1 Psma-targeted dendrimers
10/16/2013CN103351317A Imaging 18f or 11c-labelled alkylthiophenyl guanidines
10/16/2013CN102300590B Complex of bifunctional chelating agent and mannosyl human serum albumin
10/15/2013US8558003 Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders
10/15/2013US8557535 Methods for preparation of platelet rich plasma
10/15/2013US8557244 Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody
10/15/2013US8556962 Coated implantable medical device
10/10/2013WO2013150486A1 Radiotracers, preparation methods and applications
10/10/2013US20130267730 Purificiation of precursor compound by crystallisation
10/10/2013US20130266573 Specific binding proteins and uses thereof
10/10/2013US20130266513 Imaging of meningiomas using phingylbenzothiazole, stilbene, or biphenylalkyne derivatives
10/10/2013US20130266512 Tetrazine-trans-cyclooctene Ligation for the Rapid Construction of Radionuclide Labeled Probes
10/10/2013US20130266511 Novel antigen associated with the neovasculature of tumour metastases
10/10/2013US20130266508 Thermosensitive hydrogel for coating radioisotope and chemotherapeutic agent to treat cancer and method for preparing the same
10/10/2013US20130266488 Cassette for radioactive isotope handling apparatus, radioactive isotope handling apparatus, and radioactive isotope handling system
10/10/2013US20130266487 Shielding collar
10/09/2013EP2647392A2 Imaging diagnostics by combining contrast agents
10/09/2013EP2646061A1 Apoptosis pet imaging agents
10/09/2013EP2646060A2 Radioconjugation method
10/09/2013EP2646059A2 Protease degradable polypeptides and uses thereof
10/09/2013EP2646058A1 Agents for the molecular imaging of serine-protease in human pathologies
10/09/2013CN103347909A Precursor compound connected to solid support for manufacturing 18F radiopharmaceutical, method for manufacturing same, and application thereof
10/09/2013CN103342724A Preparation method and application for 99mTc-labelled hydrazino-nicotinamide-5-aminopentanoic acid-pteroyl lysine complex
10/09/2013CN103341186A Tumor-targeted radioactive nano-particles and preparation method thereof
10/09/2013CN103341185A Application of radioisotope-labeled meso-position dianthrone compound in preparation of drug for detecting myocardial activity
10/09/2013CN101370526B Recombinant monovalent antibodies and methods for production thereof
10/08/2013US8554373 Preparation and use of alkylating agents
10/08/2013US8552148 TNF-α antagonists containing IGFBP5
10/08/2013US8551506 Compositions and methods for administering compartmentalized frozen particles
10/08/2013US8551505 Compositions and methods for therapeutic delivery with frozen particles
10/08/2013US8551448 Rotanone analogs: method of preparation and use
10/08/2013US8551446 Poly(vinyl acetal) coatings for implantable medical devices
10/08/2013US8551445 Preparation and use of alkylating agents
10/08/2013CA2542898C Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents
10/08/2013CA2486307C Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
10/03/2013WO2013144879A1 Amorphous carbon supported nanoparticles comprising oxides of lanthanides and method for preparing them
10/03/2013WO2013144604A1 Biotinidase resistant biotinyl compounds
10/03/2013WO2013144301A2 Synthon composition
10/03/2013WO2013142961A1 Egfl7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis
10/03/2013US20130263296 Cancer imaging with therapy: theranostics
10/03/2013US20130259804 Radiotracer compositions
10/03/2013US20130259802 Radiofluorinated compounds and their preparation
10/03/2013US20130259799 Human gm-csf antigen binding proteins
10/02/2013EP2643024A1 177lutetium-labeled bombesin analogs for radiotherapy
10/02/2013EP2643023A1 Radioiodination method
10/02/2013EP2151250B1 Vitamin-Targeted imaging agents
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 243